Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9,968,574
Publication Date
5-15-2018
Abstract
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
Assignees
The University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
12/949,724
Filing Date
11/18/2010
Recommended Citation
Lovell, Mark A. and Lynn, Bert C., "Treatment of MCI and Alzheimer's Disease" (2018). Chemistry Faculty Patents. 37.
https://uknowledge.uky.edu/chemistry_patents/37
Included in
Chemicals and Drugs Commons, Chemistry Commons, Diseases Commons, Neuroscience and Neurobiology Commons
